These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 27242978)

  • 21. Dasatinib and chemotherapy in a patient with early T-cell precursor acute lymphoblastic leukemia and
    Chen Y; Zhang L; Huang J; Hong X; Zhao J; Wang Z; Zhang K
    Exp Ther Med; 2017 Nov; 14(5):3979-3984. PubMed ID: 29067094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of Early T-Cell Precursor and Non-ETP Subtypes Among 122 Chinese Adults With Acute Lymphoblastic Leukemia.
    Zhang Y; Qian JJ; Zhou YL; Huang X; Li JH; Li XY; Li CY; Wang HP; Lou YJ; Meng HT; Yu WJ; Tong HY; Jin J; Zhu HH
    Front Oncol; 2020; 10():1423. PubMed ID: 32974153
    [No Abstract]   [Full Text] [Related]  

  • 23. [Therapeutic strategies for childhood high-risk acute lymphoblastic leukemia].
    Lu XT
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):327-32. PubMed ID: 23591360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and molecular characterization of early T-cell precursor leukemia: a high-risk subgroup in adult T-ALL with a high frequency of FLT3 mutations.
    Neumann M; Heesch S; Gökbuget N; Schwartz S; Schlee C; Benlasfer O; Farhadi-Sartangi N; Thibaut J; Burmeister T; Hoelzer D; Hofmann WK; Thiel E; Baldus CD
    Blood Cancer J; 2012 Jan; 2(1):e55. PubMed ID: 22829239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early T-Cell Precursor Acute Lymphoblastic Leukemia in an Infant With an NRAS Q61R Mutation and Clinical Features of Juvenile Myelomonocytic Leukemia.
    Raikar SS; Scarborough JD; Sabnis H; Bergsagel J; Wu D; Cooper TM; Keller FG; Wood BL; Bunting ST
    Pediatr Blood Cancer; 2016 Sep; 63(9):1667-70. PubMed ID: 27145535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early T precursor acute lymphoblastic leukaemia/lymphoma shows differential immunophenotypic characteristics including frequent CD33 expression and in vitro response to targeted CD33 therapy.
    Khogeer H; Rahman H; Jain N; Angelova EA; Yang H; Quesada A; Ok CY; Sui D; Wei P; Al Fattani A; Pierce S; Loghavi S; Lamb A; Hu P; Thakral B; Kanagal-Shamanna R; Jorgensen JL; Jabbour EJ; Kantarjian HM; Medeiros LJ; Khoury JD
    Br J Haematol; 2019 Aug; 186(4):538-548. PubMed ID: 31115909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inside the biology of early T-cell precursor acute lymphoblastic leukemia: the perfect trick.
    Tarantini F; Cumbo C; Anelli L; Zagaria A; Specchia G; Musto P; Albano F
    Biomark Res; 2021 Dec; 9(1):89. PubMed ID: 34930475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RNA sequencing unravels the genetics of refractory/relapsed T-cell acute lymphoblastic leukemia. Prognostic and therapeutic implications.
    Gianfelici V; Chiaretti S; Demeyer S; Di Giacomo F; Messina M; La Starza R; Peragine N; Paoloni F; Geerdens E; Pierini V; Elia L; Mancini M; De Propris MS; Apicella V; Gaidano G; Testi AM; Vitale A; Vignetti M; Mecucci C; Guarini A; Cools J; Foà R
    Haematologica; 2016 Aug; 101(8):941-50. PubMed ID: 27151993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early precursor T-cell acute lymphoblastic leukemia: current paradigms and evolving concepts.
    Castaneda Puglianini O; Papadantonakis N
    Ther Adv Hematol; 2020; 11():2040620720929475. PubMed ID: 32733662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TC-PTP and PTP1B: Regulating JAK-STAT signaling, controlling lymphoid malignancies.
    Pike KA; Tremblay ML
    Cytokine; 2016 Jun; 82():52-7. PubMed ID: 26817397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peripheral blood flow cytometry for the diagnosis of pediatric acute leukemia: Highly reliable with rare exceptions.
    Cheng J; Klairmont MM; Choi JK
    Pediatr Blood Cancer; 2019 Jan; 66(1):e27453. PubMed ID: 30255571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Poor Response to Standard Chemotherapy in Early T-precursor (ETP)-ALL: A Subtype of T-ALL Associated with Unfavourable Outcome: A Brief Report.
    Iqbal N; Sharma A; Raina V; Kumar L; Bakhshi S; Kumar R; Gajendra S
    Indian J Hematol Blood Transfus; 2014 Dec; 30(4):215-8. PubMed ID: 25435716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Silencing of GATA3 defines a novel stem cell-like subgroup of ETP-ALL.
    Fransecky L; Neumann M; Heesch S; Schlee C; Ortiz-Tanchez J; Heller S; Mossner M; Schwartz S; Mochmann LH; Isaakidis K; Bastian L; Kees UR; Herold T; Spiekermann K; Gökbuget N; Baldus CD
    J Hematol Oncol; 2016 Sep; 9(1):95. PubMed ID: 27658391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T-Cell Acute Lymphoblastic Leukemia: A Cytogenomic Update.
    Nguyen AM; Okabe A; Tse V; Tirado CA
    J Assoc Genet Technol; 2020; 46(2):59-73. PubMed ID: 32526730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. T-cell transcription factor GATA-3 is an immunophenotypic marker of acute leukemias with T-cell differentiation.
    Dorfman DM; Morgan EA; Pelton A; Unitt C
    Hum Pathol; 2017 Jul; 65():166-174. PubMed ID: 28551327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polycomb repressive 2 complex-Molecular mechanisms of function.
    Kouznetsova VL; Tchekanov A; Li X; Yan X; Tsigelny IF
    Protein Sci; 2019 Aug; 28(8):1387-1399. PubMed ID: 31095801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biological and clinical significance of cytogenetic study on 100 acute lymphoblastic leukemia and 219 acute non-lymphoblastic leukemia.
    Ye J; Cao Q; Su X; Huang Q; Ma Z; Wang Z; Huang W; Chen Z; Chen S
    Chin Med J (Engl); 1997 Feb; 110(2):90-5. PubMed ID: 9594276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EZH2 is increased in paediatric T-cell acute lymphoblastic leukemia and is a suitable molecular target in combination treatment approaches.
    D'Angelo V; Iannotta A; Ramaglia M; Lombardi A; Zarone MR; Desiderio V; Affinita MC; Pecoraro G; Di Martino M; Indolfi P; Casale F; Caraglia M
    J Exp Clin Cancer Res; 2015 Aug; 34(1):83. PubMed ID: 26268310
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Mukherjee S; Kar A; Paul P; Dey S; Biswas A; Barik S
    Front Cell Dev Biol; 2022; 10():899752. PubMed ID: 35646901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Features and Prognosis According to Immunophenotypic Subtypes Including the Early T-Cell Precursor Subtype of T-Lymphoblastic Lymphoma in the Japanese Pediatric Leukemia/Lymphoma Study Group ALB-NHL03 Study.
    Fukano R; Sunami S; Sekimizu M; Takimoto T; Mori T; Mitsui T; Mori T; Saito AM; Watanabe T; Ohshima K; Fujimoto J; Nakazawa A; Kiyokawa N; Kobayashi R; Horibe K; Tsurusawa M
    J Pediatr Hematol Oncol; 2018 Jan; 40(1):e34-e37. PubMed ID: 28538509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.